atyr pharma inc (LIFE:NASDAQ GS)
John D. Mendlein Ph.D., J.D.
Executive Chairman and Chief Executive Officer, aTyr Pharma Inc.
|Age||Total Calculated Compensation||This person is connected to 67 board members in 5 different organizations across 7 different industries.|
See Board Relationships
As of Fiscal Year 2014
Dr. John D. Mendlein, Ph.D., J.D. has been the Chief Executive Officer of aTyr Pharma Inc. since September 2011 and has been its Executive Chairman since May 2010. Dr. Mendlein served as the Chief Executive Officer of Compound Therapeutics. Dr. Mendlein was the founder of Alevium Pharmaceuticals Inc., and served as its Chairman and Chief Executive Officer. He founded Fate Therapeutics, Inc. in 2007 and served as its Executive Chairman. Previously, Dr. Mendlein served ...
3545 John Hopkins CourtPhone: 858-731-8389
San Diego, California 92121
Board Members Memberships*
Vice Chairman of the Board
Executive Chairman and Chief Executive Officer
University of Miami
Hastings College of Law
University of California-Los Angeles
|There is no Competitor Compensation data available.|